Hostname: page-component-89b8bd64d-j4x9h Total loading time: 0 Render date: 2026-05-09T04:37:14.189Z Has data issue: false hasContentIssue false

Process evaluation of a randomised controlled trial of a diabetes prevention intervention in Dutch primary health care: the SLIMMER study

Published online by Cambridge University Press:  03 June 2016

Ellen JI van Dongen*
Affiliation:
Wageningen University, Division of Human Nutrition and Academic Collaborative Centre AGORA, PO Box 8129, 6700 EV Wageningen, The Netherlands
Geerke Duijzer
Affiliation:
Wageningen University, Division of Human Nutrition and Academic Collaborative Centre AGORA, PO Box 8129, 6700 EV Wageningen, The Netherlands
Sophia C Jansen
Affiliation:
GGD Noord- en Oost-Gelderland (Community Health Service), Warnsveld, The Netherlands
Josien ter Beek
Affiliation:
GGD Noord- en Oost-Gelderland (Community Health Service), Warnsveld, The Netherlands
Johanna M Huijg
Affiliation:
Leyden Academy on Vitality and Ageing, Leiden, The Netherlands
Joanne N Leerlooijer
Affiliation:
Wageningen University, Division of Human Nutrition and Academic Collaborative Centre AGORA, PO Box 8129, 6700 EV Wageningen, The Netherlands
Gerrit J Hiddink
Affiliation:
Wageningen University, Strategic Communication, Sub-department Communication, Philosophy and Technology: Centre for Integrative Development, Social Sciences, Wageningen, The Netherlands
Edith JM Feskens
Affiliation:
Wageningen University, Division of Human Nutrition and Academic Collaborative Centre AGORA, PO Box 8129, 6700 EV Wageningen, The Netherlands
Annemien Haveman-Nies
Affiliation:
Wageningen University, Division of Human Nutrition and Academic Collaborative Centre AGORA, PO Box 8129, 6700 EV Wageningen, The Netherlands GGD Noord- en Oost-Gelderland (Community Health Service), Warnsveld, The Netherlands
*
* Corresponding author: Email ellen.vandongen@wur.nl
Rights & Permissions [Opens in a new window]

Abstract

Objective

To investigate (i) how the SLIMMER intervention was delivered and received in Dutch primary health care and (ii) how this could explain intervention effectiveness.

Design

A randomised controlled trial was conducted and subjects were randomly allocated to the intervention (10-month combined dietary and physical activity intervention) or the control group. A process evaluation including quantitative and qualitative methods was conducted. Data on process indicators (recruitment, reach, dose received, acceptability, implementation integrity and applicability) were collected via semi-structured interviews with health-care professionals (n 45) and intervention participant questionnaires (n 155).

Setting

SLIMMER was implemented in Dutch primary health care in twenty-five general practices, eleven dietitians, nine physiotherapist practices and fifteen sports clubs.

Subjects

Subjects at increased risk of developing type 2 diabetes were included.

Results

It was possible to recruit the intended high-risk population (response rate 54 %) and the SLIMMER intervention was very well received by both participants and health-care professionals (mean acceptability rating of 82 and 80, respectively). The intervention programme was to a large extent implemented as planned and was applicable in Dutch primary health care. Higher dose received and participant acceptability were related to improved health outcomes and dietary behaviour, but not to physical activity behaviour.

Conclusions

The present study showed that it is feasible to implement a diabetes prevention intervention in Dutch primary health care. Higher dose received and participant acceptability were associated with improved health outcomes and dietary behaviour. Using an extensive process evaluation plan to gain insight into how an intervention is delivered and received is a valuable way of identifying intervention components that contribute to implementation integrity and effective prevention of type 2 diabetes in primary health care.

Information

Type
Research Papers
Copyright
Copyright © The Authors 2016 
Figure 0

Table 1 Details of the SLIMMER lifestyle intervention programme according to the implementation manual

Figure 1

Table 2 Baseline characteristics of participants (n 316) and non-responders (n 175) in the SLIMMER intervention*

Figure 2

Table 3 Dose of the SLIMMER intervention components received by the intervention group (n 155)*

Figure 3

Table 4 Acceptability (score 0–100) of the SLIMMER intervention by the intervention group (n 144) and health-care professionals (n 44)*

Figure 4

Table 5 Associations between process indicators (dose received and acceptability) and intervention effectiveness of the SLIMMER intervention (n 144)*,†